Yuki Tabata Selected Research

geranylgeranic acid

2/2022	Hepatic CYP3A4 Enzyme Compensatively Maintains Endogenous Geranylgeranoic Acid Levels in MAOB-Knockout Human Hepatoma Cells.
9/2021	Age-Dependent Decrease in Hepatic Geranylgeranoic Acid Content in C3H/HeN Mice and Its Oral Supplementation Prevents Spontaneous Hepatoma.
1/2020	Hepatic monoamine oxidase B is involved in endogenous geranylgeranoic acid synthesis in mammalian liver cells.
1/2019	Unequivocal evidence for endogenous geranylgeranoic acid biosynthesized from mevalonate in mammalian cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuki Tabata Research Topics

Disease

4	Hepatocellular Carcinoma (Hepatoma) 02/2022 - 01/2019
1	Osteoporosis 06/2022
1	Neoplasms (Cancer) 09/2021

Drug/Important Bio-Agent (IBA)

4	geranylgeranic acidIBA 02/2022 - 01/2019
2	Small Interfering RNA (siRNA)IBA 02/2022 - 01/2020
2	geranylgeraniolIBA 02/2022 - 01/2020
2	Mevalonic Acid (Mevalonate)IBA 02/2022 - 09/2021
2	EnzymesIBA 02/2022 - 01/2020
1	Parathyroid Hormone (Parathormone)IBA 06/2022
1	Cytochrome P-450 CYP3AIBA 02/2022
1	alternative oxidaseIBA 02/2022
1	Monoamine Oxidase (MAO)IBA 02/2022
1	Tranylcypromine (Parnate)FDA LinkGeneric 02/2022
1	Messenger RNA (mRNA)IBA 09/2021
1	squalestatin 1IBA 09/2021
1	Oxygen (Dioxygen)IBA 01/2020
1	mevalonolactoneIBA 01/2019
1	LipidsIBA 01/2019

Therapy/Procedure

1	Oral Administration 09/2021